Sunil Badve's Publications

About Sunil Badve's Publications

Program Lead, Cardiometabolic Trials, Renal and Metabolic Program

  • A nephrology guide to reading and using systematic reviews of randomized trials

    Nephrology Dialysis Transplantation Date published:

  • The Association between Peritoneal Dialysis Modality and Peritonitis

    Clinical Journal of the American Society of Nephrology Date published:

  • Biocompatible dialysis fluids for peritoneal dialysis

    Cochrane Database of Systematic Reviews Date published:

  • Peritoneal dialysis outcomes after temporary haemodialysis transfer for peritonitis

    Nephrology Dialysis Transplantation Date published:

  • Haemodialysis catheter care in practice

    Nature Reviews Nephrology Date published:

  • Erythropoiesis stimulating agent resistance

    Date published:

  • Establishing a clinical trials network in nephrology: experience of the Australasian Kidney Trials Network

    Kidney International Date published:

  • Antibacterial honey for the prevention of peritoneal-dialysis-related infections (HONEYPOT): a randomised trial

    The Lancet Infectious Diseases Date published:

  • Erythropoiesis stimulating agent resistance

    Advances in Drug Resistance Research Date published:

  • MICROBIOLOGICAL RESULTS OF THE HONEYPOT STUDY - SECONDARY ANALYSIS OF A RANDOMISED, CONTROLLED TRIAL OF EXIT SITE APPLICATION OF MEDIHONEY FOR THE PREVENTION OF CATHETER-ASSOCIATED INFECTIONS IN PD PATIENTS

    Nephrology Date published:

  • THE EFFECT OF PENTOXIFYLLINE ON OXIDATIVE STRESS MARKERS: SUBSTUDY OF THE HERO TRIAL

    Nephrology Date published:

  • INTERVENTIONS FOR REDUCTION OF LEFT VENTRICULAR MASS IN CHRONIC KIDNEY DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS

    Nephrology Date published:

  • A RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF PENTOXIFYLLINE ON ERYTHROPOIESIS STIMULATING AGENT RESISTANCE IN ANAEMIC PATIENTS WITH CHRONIC KIDNEY DISEASE - THE HERO TRIAL

    Nephrology Date published:

  • Biocompatible dialysis fluids for peritoneal dialysis.

    The Cochrane Database of Systematic Reviews Date published:

  • The impact of neutral-pH peritoneal dialysates with reduced glucose degradation products on clinical outcomes in peritoneal dialysis patients

    Kidney International Date published:

  • Association of Biocompatible Peritoneal Dialysis Solutions with Peritonitis Risk, Treatment, and Outcomes

    Clinical Journal of the American Society of Nephrology Date published: